Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01415583
Other study ID # 10-03-016
Secondary ID
Status Completed
Phase N/A
First received October 27, 2010
Last updated April 19, 2012
Start date July 2010
Est. completion date November 2011

Study information

Verified date April 2012
Source Massachusetts Eye and Ear Infirmary
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Tonsillectomy (removal of the tonsils) is a very common surgery in children. Bleeding after tonsillectomy is one of the risks of this surgery and can be more dangerous in children since they have less blood volume than adults. In order to improve recovery after tonsillectomy, steroids (medication that is a strong anti-inflammatory) are often given during the surgery. Recently, a study showed steroids given at the time of tonsillectomy increase the risk of bleeding significantly over children who did not receive steroids. This finding has raised concerns in the Ear, Nose, and Throat (ENT) community since most ENT's use steroids during tonsillectomy in children. The investigators look to explore this question further.

To answer the question of whether perioperative steroid administration significantly affects the rate of post-tonsillectomy bleeding, the investigators propose to test the following hypotheses in a prospective, randomized, blinded placebo-controlled trial: dexamethasone does not cause an increase in post-operative bleeding rate in tonsillectomy.


Description:

Not desired


Recruitment information / eligibility

Status Completed
Enrollment 314
Est. completion date November 2011
Est. primary completion date November 2011
Accepts healthy volunteers No
Gender Both
Age group 3 Years to 18 Years
Eligibility Inclusion Criteria:

- Patients ages 3 to 18 undergoing tonsillectomy or adenotonsillectomy by electrocautery alone for the indication of sleep disordered breathing or infectious tonsillitis.

- Patients with complex medical conditions or craniofacial abnormalities will be included.

- Informed consent and child assent are required for enrollment.

- Eligibility will be determined by the principal investigator, associate investigator or research nurse.

Exclusion Criteria:

- Subjects with a known personal or family history of any bleeding disorder will be excluded.

- Subjects currently on oral corticosteroids for other medical conditions or have recently taken any oral corticosteroid within two weeks of surgery.

- Patients with tonsillectomy performed using a cold knife technique, microdebrider, coblation or plasma knife due to surgeon or parent preference.

- Where appropriate subjects who do not have informed consent or child assent signed will be excluded

- Children less than three years old will be excluded due to the fact the majority of these children at the collaborating centers have an adenotonsillectomy using the microdebrider for pain control purposes.

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Intervention

Drug:
Dexamethasone
0.5mg/kg (max dose 20mg)

Locations

Country Name City State
United States Massachusetts Eye and Ear Infirmary Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Massachusetts Eye and Ear Infirmary

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with post-tonsillectomy bleeding The primary objective of this study is to determine if dexamethasone at 0.5mg/kg (max dose 20mg) is associated with an increased rate of post-tonsillectomy hemorrhage in children when compared to placebo. 2 weeks after surgery Yes
Secondary To compare rate of post-tonsillectomy hemorrhage when studying different groups of patients based on age, indication for surgery, or operating surgeon. The second objective of this study is to use a multivariate logistic regression model to determine if bleeding rates differed according to surgical indication, age, or operating surgeon. This is important since indication for tonsillectomy varies in children. Younger children tend to undergo tonsillectomy for obstructive sleep symptoms whereas older children tend to have the indication for tonsillectomy based on infectious tonsillitis. 2 weeks after surgery Yes